LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | barcode | cell_count | frac_dead | corpse_count | cell_count_dead | row | column | agent | concentration | role | timepoint | replicate | cell_line | dead_count | fraction_dead | cell_count__time0 | dead_count__time0 | cell_count__ctrl | dead_count__ctrl | fraction_dead__ctrl | increase_fraction_dead | GRvalue |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neratinib | 180614_BG_04 | 14872 | 0.0180 | 101 | 169 | 8 | 15 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_8 | 270 | 0.0178 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00216 | 0.9368 |
Neratinib | 180614_BG_04 | 16625 | 0.0216 | 112 | 249 | 8 | 18 | Neratinib | 0.031603333 | treatment | 72 | 1 | MCF10A-GM_9 | 361 | 0.0213 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00126 | 0.9881 |
Neratinib | 180614_BG_02 | 7270 | 0.0201 | 33 | 114 | 11 | 14 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_1 | 147 | 0.0198 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00018 | 0.6374 |
Neratinib | 180614_BG_02 | 7608 | 0.0227 | 44 | 130 | 14 | 15 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_2 | 174 | 0.0224 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00236 | 0.6549 |
Neratinib | 180614_BG_02 | 7034 | 0.0187 | 15 | 117 | 14 | 18 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_3 | 132 | 0.0184 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00158 | 0.6247 |
Neratinib | 180614_BG_03 | 13609 | 0.0226 | 79 | 231 | 6 | 5 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_4 | 310 | 0.0223 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00228 | 0.8969 |
Neratinib | 180614_BG_03 | 14016 | 0.0184 | 67 | 192 | 8 | 6 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_5 | 259 | 0.0181 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00185 | 0.9100 |
Neratinib | 180614_BG_03 | 14256 | 0.0169 | 55 | 187 | 9 | 5 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_6 | 242 | 0.0167 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00330 | 0.9176 |
Neratinib | 180614_BG_04 | 17242 | 0.0236 | 131 | 279 | 8 | 5 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_7 | 410 | 0.0232 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00323 | 1.0051 |
Neratinib | 180614_BG_04 | 16207 | 0.0230 | 132 | 243 | 11 | 15 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_8 | 375 | 0.0226 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00262 | 0.9762 |
Neratinib | 180614_BG_04 | 15938 | 0.0187 | 90 | 210 | 12 | 7 | Neratinib | 0.099799997 | treatment | 72 | 1 | MCF10A-GM_9 | 300 | 0.0185 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | -0.00152 | 0.9685 |
Neratinib | 180614_BG_02 | 2236 | 0.0440 | 37 | 63 | 3 | 5 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_1 | 100 | 0.0428 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.02281 | 0.2416 |
Neratinib | 180614_BG_02 | 2855 | 0.0287 | 32 | 51 | 10 | 8 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_2 | 83 | 0.0283 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00825 | 0.3149 |
Neratinib | 180614_BG_02 | 2587 | 0.0393 | 31 | 72 | 11 | 19 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_3 | 103 | 0.0383 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01829 | 0.2848 |
Neratinib | 180614_BG_03 | 3540 | 0.0254 | 40 | 51 | 3 | 22 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_4 | 91 | 0.0251 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00507 | 0.3830 |
Neratinib | 180614_BG_03 | 4769 | 0.0235 | 35 | 78 | 9 | 16 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_5 | 113 | 0.0231 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00315 | 0.4831 |
Neratinib | 180614_BG_03 | 4630 | 0.0318 | 88 | 62 | 14 | 9 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_6 | 150 | 0.0314 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01139 | 0.4729 |
Neratinib | 180614_BG_04 | 8218 | 0.0259 | 125 | 91 | 4 | 6 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_7 | 216 | 0.0256 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00562 | 0.6851 |
Neratinib | 180614_BG_04 | 6144 | 0.0386 | 146 | 97 | 5 | 17 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_8 | 243 | 0.0380 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.01805 | 0.5740 |
Neratinib | 180614_BG_04 | 8071 | 0.0232 | 79 | 110 | 9 | 16 | Neratinib | 0.299399965 | treatment | 72 | 1 | MCF10A-GM_9 | 189 | 0.0229 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.00289 | 0.6780 |
Neratinib | 180614_BG_02 | 1544 | 0.0852 | 41 | 94 | 10 | 3 | Neratinib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_1 | 135 | 0.0804 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.06041 | 0.1383 |
Neratinib | 180614_BG_02 | 1426 | 0.0758 | 26 | 84 | 10 | 21 | Neratinib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_2 | 110 | 0.0716 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.05162 | 0.1173 |
Neratinib | 180614_BG_02 | 1473 | 0.0876 | 23 | 108 | 11 | 20 | Neratinib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_3 | 131 | 0.0817 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.06168 | 0.1258 |
Neratinib | 180614_BG_03 | 1577 | 0.0829 | 76 | 61 | 3 | 12 | Neratinib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_4 | 137 | 0.0799 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.05993 | 0.1440 |
Neratinib | 180614_BG_03 | 1766 | 0.0627 | 53 | 61 | 9 | 8 | Neratinib | 0.997999609 | treatment | 72 | 1 | MCF10A-GM_5 | 114 | 0.0606 | 889.0 | 105.5 | 17054 | 348.0 | 0.0200 | 0.04064 | 0.1748 |